Please login to the form below

Not currently logged in
Email:
Password:

Activity

This page shows the latest Activity news and features for those working in and with pharma, biotech and healthcare.

FDA sets January decision date for Xalkori in ALK-positive lymphoma

FDA sets January decision date for Xalkori in ALK-positive lymphoma

Across both studies, Xalkori demonstrated encouraging anti-tumour activity with Xalkori in children and adults with ALK-positive ALCL. ... The ADVL0912 evaluated the maximum safe and tolerable dose of the TKI, and also investigated the clinical activity

Latest news

More from news
Approximately 0 fully matching, plus 2,016 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 349 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 151 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 290 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Latest intelligence

3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....
Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...

Infographics